Here are four things to know:
1. The new patent covers bone implants for the treatment of infection.
2. Silver Bullet Therapeutics develops and patents antimicrobial implants and medical devices to address surgical-site and hospital-acquired infections.
3. The company’s first commercial product, the OrthoFuzIon Bone Screw System, uses advanced silver ion technology that creates an antimicrobial zone.
4. The company also announced it has made an expedited CE Mark filing for an expanded OrthoFuzIon Antimicrobial Bone Screw System product line.
More articles on devices:
Materialise, Mathys pen agreement — 4 highlights
Amedica to present clinical trial for CASCADE — 5 notes
Arthrex named one of Fortune’s 15 best workplaces for production: 4 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
